Ischaemic Stroke Causes
Ischaemic Stroke Causes
Every ischaemic stroke has a clot at the end of the story, but the clot is where the story finishes rather than where it starts. Behind it sits a mechanism: a plaque in an artery, a rhythm disorder in the heart, disease of the small vessels deep in the brain, or one of the less common causes that matter enormously when they apply. The mechanism is what determines treatment for the following years, and it is why a stroke assessment that stops at the diagnosis has answered the smaller of its two questions.
Atherosclerosis of the arteries to the brain
What matters clinically is not the presence of a narrowing but whether it has caused symptoms. A tight stenosis discovered by chance in someone who has never had symptoms is a different problem from the same stenosis in someone who has just had a transient episode or a small stroke in the territory that artery supplies — and it is the symptomatic one that carries a high risk of a further event in the weeks immediately after. This is the reason that imaging of the neck arteries is part of the standard assessment after any stroke or transient attack, because two mechanisms can be present at once, and treating one while leaving the other is a common way to have a second stroke.
A clot from the heart: why the rhythm matters
The heart can be the source of the clot rather than the arteries, and when it is, the consequences are different in two important ways: the stroke is often larger, because a clot formed in a chamber can be large and can block a major vessel; and the treatment is different, because the drug class that works is anticoagulation rather than antiplatelet medication. Missing this mechanism is therefore one of the more costly errors in stroke care.
The commonest cardiac source is atrial fibrillation, in which the upper chambers stop contracting in an organised way and blood can stagnate and clot. Its defining difficulty is that it comes and goes. A patient may be in normal rhythm when the ambulance arrives, on the monitor, and at the clinic a week later — while having had several hours of atrial fibrillation in between. Detection therefore depends on prolonged monitoring rather than a single electrocardiogram,
Disease of the small vessels deep in the brain
The arteries that penetrate the deep structures of the brain are small, and they are the ones most affected by many years of high blood pressure and diabetes. The disease is one of the vessel walls rather than of the channel: the wall thickens and the lumen closes, producing a small infarct in a specific place rather than a large one. These are called lacunar strokes, and because the affected structures carry tightly packed nerve fibres, a very small infarct can produce a very definite deficit.
Lacunar stroke matters for what it rules out as much as for what it is: there is no vessel here to be opened and no plaque to be treated. What can be done is long-term management — blood pressure first, alongside glucose, lipids and lifestyle — rather than any procedure. Routing a patient of this type towards an interventional option is precisely the mismatch this guide exists to prevent.
The less common mechanisms, and why they matter out of proportion
These account for a minority of strokes, and they matter because in each of them the correct treatment is different from routine stroke care — and because several of them are the answers in patients whose age makes the usual causes unlikely.
| Mechanism | How it is recognised | Why it changes treatment |
|---|---|---|
| Arterial dissection | A tear in the wall of a neck artery, often after neck trauma, manipulation or in a connective-tissue disorder; imaging shows the flap or the narrowing | Anticoagulation or antiplatelet treatment with specific follow-up imaging to confirm healing, and a search for an underlying connective-tissue condition |
| Clotting disorders | Blood tests for thrombophilia, particularly in younger patients, in recurrent events, or where venous clots have also occurred | May change the choice and the duration of blood-thinning treatment, and the management of pregnancy and surgery |
| Inflammatory disease of the arteries | Vasculitis affecting the brain, or systemic inflammation with neurological involvement; imaging and inflammatory markers | Treatment is immunosuppression rather than routine stroke prevention, and it is given by a rheumatology or immunology team |
| Blood disorders | Abnormalities of the cells or of haemoglobin that make the blood more likely to clot or less able to carry oxygen | Management is directed at the haematological condition; transfusions and specific drugs may be involved |
| Drugs, pregnancy and the postpartum period | A medication or substance history, and the pregnancy status of any woman of childbearing age with a stroke | Both raise the risk of clotting and both change which drugs can be used; management is shared with obstetrics |
Stroke in younger adults: a different list of suspects
Stroke is a disease of older age in the great majority of patients, but it is not confined to it, and the mechanism in a patient of thirty-five is more likely to be found on the list above than on the list at the top of this page. Dissection, clotting disorders, a hole in the heart, inflammatory disease and the complications of pregnancy belong to this group, and so does the use of some drugs.
The consequence is a single instruction: a stroke in a younger adult should widen the investigation, not narrow it. Explaining an uncommon stroke with a common cause is the commonest way a mechanism is missed in younger patients.
Three things that are believed about stroke and are not true
- "It only happens to elderly people." The risk rises steeply with age, which is not the same as being confined to it. A substantial number of strokes occur in working-age adults, and in that group the mechanisms are disproportionately the ones that need specialist investigation.
- "High blood pressure only matters if you can feel it." Blood pressure produces no sensation at all until it causes damage. It is the single most important modifiable risk factor for stroke, and it is found by measurement rather than by symptoms.
- "A stroke is over once the symptoms stop getting worse." The infarct evolves over hours and the risk of a further event is highest in the days immediately afterwards. Both processes are active after the patient has stopped changing.
What changes when the cause is known
- Which drug, and why. Anticoagulation for a cardiac source, antiplatelet treatment for arterial disease, and mechanism-specific approaches for dissection or inflammatory disease — three different programmes that are not interchangeable.
- Whether a procedure is relevant. A symptomatic narrowing of the carotid artery may be repaired; small-vessel disease is treated with medication alone and no procedure changes it.
- What is monitored, and for how long. A cardiac source means continued rhythm surveillance; an inherited clotting disorder means implications for family members and for pregnancy; a cryptogenic stroke means monitoring continues rather than concludes.
- What the patient can act on. A mechanism that can be modified — smoking, blood pressure, alcohol, a drug — should be named explicitly and written into the plan, because that is the part of prevention that belongs to the patient rather than to the clinic.